1135 related articles for article (PubMed ID: 28844960)
21. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
22. TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.
Masyuk TV; Masyuk AI; Lorenzo Pisarello M; Howard BN; Huang BQ; Lee PY; Fung X; Sergienko E; Ardecky RJ; Chung TDY; Pinkerton AB; LaRusso NF
Hepatology; 2017 Oct; 66(4):1197-1218. PubMed ID: 28543567
[TBL] [Abstract][Full Text] [Related]
23. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
[TBL] [Abstract][Full Text] [Related]
24. Regulators of Cholangiocyte Proliferation.
Hall C; Sato K; Wu N; Zhou T; Kyritsi K; Meng F; Glaser S; Alpini G
Gene Expr; 2017 Feb; 17(2):155-171. PubMed ID: 27412505
[TBL] [Abstract][Full Text] [Related]
25. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
[TBL] [Abstract][Full Text] [Related]
26. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.
Cariello M; Piccinin E; Garcia-Irigoyen O; Sabbà C; Moschetta A
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1308-1318. PubMed ID: 28965883
[TBL] [Abstract][Full Text] [Related]
27. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells.
Keitel V; Reinehr R; Gatsios P; Rupprecht C; Görg B; Selbach O; Häussinger D; Kubitz R
Hepatology; 2007 Mar; 45(3):695-704. PubMed ID: 17326144
[TBL] [Abstract][Full Text] [Related]
28. TGR5 in the biliary tree.
Keitel V; Häussinger D
Dig Dis; 2011; 29(1):45-7. PubMed ID: 21691103
[TBL] [Abstract][Full Text] [Related]
29. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
30. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.
Alvarez-Sola G; Uriarte I; Latasa MU; Jimenez M; Barcena-Varela M; Santamaría E; Urtasun R; Rodriguez-Ortigosa C; Prieto J; Berraondo P; Fernandez-Barrena MG; Berasain C; Avila MA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1326-1334. PubMed ID: 28709961
[TBL] [Abstract][Full Text] [Related]
31. Genetic determinants of cholangiopathies: Molecular and systems genetics.
Reichert MC; Hall RA; Krawczyk M; Lammert F
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1484-1490. PubMed ID: 28757171
[TBL] [Abstract][Full Text] [Related]
32. Expression and function of the bile acid receptor TGR5 in Kupffer cells.
Keitel V; Donner M; Winandy S; Kubitz R; Häussinger D
Biochem Biophys Res Commun; 2008 Jul; 372(1):78-84. PubMed ID: 18468513
[TBL] [Abstract][Full Text] [Related]
33. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
[TBL] [Abstract][Full Text] [Related]
34. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
35. Novel and emerging therapies for cholestatic liver diseases.
Goldstein J; Levy C
Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
[TBL] [Abstract][Full Text] [Related]
36. Perspective: TGR5 (Gpbar-1) in liver physiology and disease.
Keitel V; Häussinger D
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):412-9. PubMed ID: 22521118
[TBL] [Abstract][Full Text] [Related]
37. Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors.
Keitel V; Stindt J; Häussinger D
Handb Exp Pharmacol; 2019; 256():19-49. PubMed ID: 31302759
[TBL] [Abstract][Full Text] [Related]
38. TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function.
Merlen G; Kahale N; Ursic-Bedoya J; Bidault-Jourdainne V; Simerabet H; Doignon I; Tanfin Z; Garcin I; Péan N; Gautherot J; Davit-Spraul A; Guettier C; Humbert L; Rainteau D; Ebnet K; Ullmer C; Cassio D; Tordjmann T
Gut; 2020 Jan; 69(1):146-157. PubMed ID: 30723104
[TBL] [Abstract][Full Text] [Related]
39. TGR5 signaling mitigates parenteral nutrition-associated liver disease.
Willis KA; Gomes CK; Rao P; Micic D; Moran ER; Stephenson E; Puchowicz M; Al Abdallah Q; Mims TS; Gosain A; Yin D; Talati AJ; Chang EB; Han JC; Pierre JF
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G322-G335. PubMed ID: 31905022
[TBL] [Abstract][Full Text] [Related]
40. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
